Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Trans-N1-((1R,2S)-2-phenylcyclopropyl)cyclohexane-1,4-diamine bis-hydrochloride

EU orphan designation number: EU/3/13/1174   
Active ingredient: Trans-N1-((1R,2S)-2-phenylcyclopropyl)cyclohexane-1,4-diamine bis-hydrochloride
Indication: Treatment of acute myeloid leukaemia
Sponsor: Roche Registration Limited
6 Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
08/08/2013 Orphan Designation EMA/OD/064/13 (2013)5273 of 05/08/2013
08/12/2014 Transfer of orphan designation EMA/OD/064/13/T/01 (2014)9378 of 03/12/2014